antileukemic
antileukemia
ponatinib
venetoclax
thioguanine
leukemogenicity
idelalisib
leukemic
leukemogenic
acute leukemia
ubenimex
chloraminophene
leukemogenically
nonleukemogenic
promyeloleukemia
leukaemogenesis
pegaspargase
chronic leukemia
leukemogenesis
trilaciclib
acute lymphoblastic leukemia
lenzilumab
tyrosine kinase inhibitor
vosaroxin
chemo
alemtuzumab
nonleukemic
clofarabine
leukaemic
chemoradioimmunotherapy
leukemoid
antideath
erythroleukemic
olutasidenib
chemoimmune
aracytine
myeloid leukemia
colorology
chronic myelocytic leukemia
omacetaxine
lymphosuppressive
lumiliximab
immunochemotherapy
erythroleukemia
talacotuzumab
antimalarial
chemoimmunotherapy
asciminib
anticarcinoma
erythroleukosis